Akebia Therapeutics Amends Executive Severance Agreement with John P. Butler.

Akebia Therapeutics, Inc. and John P. Butler have entered into an amended and restated executive severance agreement, effective January 28, 2025. The agreement amends and restates the original executive severance agreement dated March 3, 2014, and provides certain severance benefits to Butler contingent upon termination of employment under specified circumstances. The agreement outlines the terms of severance pay, continuation of health benefits, and other benefits, as well as conditions for vesting and payment of severance.